NDA

A New Drug Application: The comprehensive document submitted by a drug manufacturer to the FDA seeking approval for the commercial deployment of a drug or, colloquially, receipt of approval. NDAs are typically thousands of pages in length and detail the results of years of study on the underlying pharmacology, chemistry, manufacturing methods, analytics, safety, preclinical science and clinical efficacy of the new drug.


 

This website uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies.